Frequently Asked Questions About Biogen Inc (BIIB) Stock
Biogen Inc's (BIIB) last reported annual revenue was USD 9.84 Billion.
Biogen Inc's (BIIB) annual revenue growth rate based on the revenue reported in the past 5 years is : -6.07%
Biogen Inc's(BIIB) is profitable as of its last reported annual financials.
The net profit margin for Biogen Inc's(BIIB) from its laster reported year is 11.81%
The return on equity (ROE) for Biogen Inc's(BIIB) from its last reported annual financials is : 10.47%
The return on assets (ROA) for Biogen Inc's(BIIB) from its last reported annual financials is : 4.99%
The return on invested capital (ROIC) for Biogen Inc's(BIIB) from its last reported annual financials is : 5.61%
The Debt to Equity ratio for Biogen Inc's(BIIB) from its last reported annual financials is : 45.87%
The dividend yield for Biogen Inc's(BIIB) from its laster reported year is 0.00%
Biogen Inc's(BIIB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIIB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
